InterMune pulmonary fibrosis drug receives EU approval
Esbriet is a small-molecule drug which is orally active, and inhibits the synthesis of TGF-beta, a chemical mediator that controls several cell functions and is important in fibrosis.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
OraSure Technologies’ Intercept Drug Testing System is the FDA-cleared in vitro diagnostic laboratory-based oral fluid testing system used for detecting commonly abused drugs such as marijuana, cocaine, opiates,